www.fdanews.com/articles/70264-mivt-receives-grant-to-expedite-development-of-hap-stent-coating
MIVT Receives Grant to Expedite Development of HAp Stent Coating
March 24, 2005
MIV Therapeutics (MIVT) announced that its wholly owned subsidiary, MIVI Technologies -- which is involved in the research and development of multilayer coating technologies with drug eluting capability for cardiovascular stents and other implantable devices -- has received a government grant for the research program titled, "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents."
TMCnet.com (http://www.tmcnet.com/usubmit/2005/Mar/1127548.htm)